HUMA
Humacyte, Inc. · Healthcare
Director and 10% owner Brady W Dougan sold $1.6M of Humacyte, Inc.
Sold$1,558,750
$3.12Price
500,000Shares
−4%Stake
What HUMA did after the filing
- The stock from Tue, Jun 20 open, $3.23
- −3.4%
- S&P 500, same days
- +2.9%
Measured over 30 trading days, to the Aug 2 close.
Traded Thu, Jun 15. Filed Fri, Jun 16. Returns use the Jun 20 open and the Aug 2 close. Not investment advice.